Introduction {#s01}
============

The obligate intracellular bacterial pathogen *Chlamydia trachomatis* is the most prevalent bacterial cause of sexually transmitted diseases and the causative agent of preventable infectious blindness ([@bib6]). *C. trachomatis* exhibits a biphasic developmental life cycle unique to the members of the phylum Chlamydiae. The small (∼0.3 µm) elementary body (EB) is the infectious form of the pathogen, which attaches to the host cell and undergoes endocytosis. After endocytosis, EBs dwell within a membrane-bound inclusion and eventually transit into the metabolically active reticulate bodies (RBs; [@bib47]; [@bib52]; [@bib1]) The RBs replicate by binary fission and differentiate back into the EB form to bring the developmental cycle to fruition. At the end of the developmental cycle, the infected cells lyse and release infectious EBs that infect new cells ([@bib78]; [@bib31]; [@bib45]).

*C. trachomatis*, an extremely sophisticated and adaptive pathogen, has a very small, albeit streamlined (∼1.04 Mb), genome ([@bib74]). Even though the chlamydial genome encodes several glucose-metabolizing enzymes, it also expresses an ATP/ADP transporter as an immediate early gene, highlighting the fact that the pathogen is not entirely independent of the host cell ATP production ([@bib52]; [@bib49]; [@bib87]; [@bib55]; [@bib21]). Indeed, cells afflicted with *C. trachomatis* infection exhibit elevated lipid biosynthesis and NADPH consumption ([@bib24]; [@bib75]). Thus, to ensure the supply of metabolites for chlamydial development and replication, the host cell is required to withstand and survive the enormous stress generated as a result of the infection.

*C. trachomatis* uses a multitude of strategies to inhibit host cell apoptosis ([@bib16]; [@bib61]; [@bib37]). Among other pathways, degradation of p53 is one of the key aspects of such resilience of the *C. trachomatis*--infected host cell to pro-apoptotic stimuli ([@bib27]). We have recently shown that *C. trachomatis* infection is affected by the p53-mediated down-regulation of the pentose phosphate pathway ([@bib71]), which connects *C. trachomatis*--induced apoptotic resistance to the host cell bioenergetics.

Whereas the bioenergetics of *C. trachomatis*--infected cells has been the focus of several studies, very little is known about the effect of the infection on the mitochondria and associated dynamics of the mitochondrial network. Mitochondria play a significant role in apoptosis, and evidence shows that alterations in the mitochondrial architecture and dynamics contribute to and are governed by the general metabolic health of the cell ([@bib11]; [@bib38]). Furthermore, mitochondrial fission and the regulator of mitochondrial fission Drp1 are influenced by increased metabolic demands and apoptotic stress ([@bib12]; [@bib62]). Recently, it has come to light that the regulation of mitochondrial dynamics is also governed by miRNAs ([@bib84]; [@bib76]).

Small noncoding RNAs such as miRNAs have emerged as regulators of host cell apoptotic pathways by influencing gene expression of several key modulators, including p53 ([@bib40]; [@bib58]; [@bib30]). miRNAs have also been implicated in the regulation of host cell bioenergetics and metabolism ([@bib17]; [@bib25]; [@bib63]). Additionally, several studies show that bacterial infections directly and indirectly affect the host immuno-metabolic ([@bib18]; [@bib15]), apoptotic ([@bib28]; [@bib74]; [@bib51]), and autophagic ([@bib85]) responses by modulation of miRNA and gene expression profiles.

In this study, we applied a high-throughput miRNA sequencing approach to study the effect of *C. trachomatis* infection on the miRNA expression profile of host cells. We show that the *C. trachomatis*--induced up-regulation of the host miRNA miR-30c-5p (hereafter, miR-30c) plays an important role in the p53-mediated down-regulation of Drp1, thereby inhibiting stress-induced mitochondrial fission and promoting cell survival during infection.

Results {#s02}
=======

*C. trachomatis* infection affects the miRNome of the host and down-regulates p53 in a miR-30c--dependent manner {#s03}
----------------------------------------------------------------------------------------------------------------

To identify differentially expressed miRNAs in *C. trachomatis*--infected primary human umbilical vein endothelial cells (HUVECs) versus noninfected samples, we used a high-throughput approach to sequence the miRNome of the samples. Analysis of miRNA deep sequencing data and validation of some of the candidate miRNAs revealed that *C. trachomatis*--infected HUVECs exhibit differential regulation of the selected miRNAs ([Fig. 1 A](#fig1){ref-type="fig"} and Fig. S1, A--D), some of which have been shown to be involved in cell death regulation and carcinogenesis ([@bib86]; [@bib41]; [@bib20]). One of the up-regulated miRNAs, miR-30c, has been shown to directly target the p53 mRNA ([@bib42]), which is concordant with the previous observations of p53 down-regulation in *C. trachomatis*--infected cells ([@bib27]; [@bib71]). Therefore, we focused further research on miR-30c. After 24 h of *C. trachomatis* infection, up-regulation of miR-30c could be detected not only by miRNA sequencing in HUVECs ([Fig. 1, A and B](#fig1){ref-type="fig"}), but also by quantitative real-time PCR (qRT-PCR) in HUVECs ([Fig. 1 C](#fig1){ref-type="fig"}) and Northern blot in HUVECs, primary epithelial cells of the human fallopian tube fimbriae (hFIMB cells; [Fig. 1, D and E](#fig1){ref-type="fig"}), and primary human foreskin fibroblasts (HFF; Fig. S1 E). We then modulated the levels of miR-30c by transfecting mimics and inhibitors into HUVECs before infection. Transfection of miR-30c mimic promotes, whereas inhibition negatively affects, chlamydial growth in HUVECs ([Fig. 2 A](#fig2){ref-type="fig"}). Additionally, we used an inducible miR-30c sponge to create a miR-30c knockdown HeLa cell line. Anhydrous tetracycline (AHT)--induced expression of the sponge, determined by increase in p53, caspase 3, and DRP1 levels (Fig. S1, F and G) and GFP expression (Fig. S1, H and I), reduced the ability of *C. trachomatis* to grow and develop ([Fig. 2, B--D](#fig2){ref-type="fig"}) and produce infectious progeny (Fig. S1 J). The effect of AHT alone on *C. trachomatis* growth was insignificant (Fig. S1 K). At the same time, HeLa cells expressing the miR-30c sponge exhibited a marked decrease in mitochondrial fragment length and an increase in mitochondrial fragment count as observed by confocal microscopy ([Fig. 2, E and F](#fig2){ref-type="fig"}). A similar effect on mitochondria was observed when miR-30c was artificially modulated in HUVECs using mimics and inhibitors (Fig. S1, L--N).

![***C. trachomatis* infection increases miR-30c abundance in multiple cell types.** (A) Heat map represents log2 fold changes of several miRNAs derived from RNA sequencing. miRNAs reported to be pro-apoptotic are labeled in green, and those reported to be anti-apoptotic are labeled in red. (B) Graph represents the log2 fold changes of miR-30c determined by miRNA deep sequencing of HUVECs after 12 and 24 h of *C. trachomatis* (C.tr) infection compared with noninfected samples. (C) Graph represents quantification of miR-30c up-regulation upon *C. trachomatis* infection by qRT-PCR. U6 snRNA was used as endogenous control for qRT-PCR. Cells were infected for 12, 24, and 36 h, and fold changes were normalized to miR-30c expression of noninfected cells at 36 h. Fold change with qRT-PCR for HUVECs (± SD) at 24 h, 2.96 ± 0.47; and 36 h, 4.87 ± 0.46 (*n* = 6). (D and E)Northern blots of HUVEC and hFIMB cell RNA, probed for U6 SnRNA, miR-30c, and the chlamydial small RNA, CtrR5. Fold change with Northern blot for HUVECs (± SD) at 24 h, 3.9 ± 0.58; and 36 h, 5.76 ± 0.72 (*n = 5*). Fold changes were normalized to miR-30c expression in noninfected cells at 12, 12, and 36 h, respectively (*n = 6* experiments). All data represents mean ± SD. Asterisks denote significance by Student's *t* test. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, nonsignificant. See also Fig. S1.](JCB_201608063_Fig1){#fig1}

![***C. trachomatis* infection down-regulates p53 in a miR-30c--dependent manner.** (A) Immunoblot of HUVECs transfected with siRNA negative control, miR-30c mimic, or inhibitor for 36 h followed by *C. trachomatis* (C.tr) infection for 12 h. The blots were probed with antibodies against the miR-30c target p53, chlamydial outer membrane protein A (cOmpA), and β-actin. (B) Immunoblot of HeLa cells expressing miR-30c sponge after AHT induction. Blots were probed with antibodies against miR-30c target p53, cOmpA, and β-actin. Induced and noninduced cells were infected with *C. trachomatis* for 24 and 36 h. (C) Sponge-mediated miR-30c depletion in HeLa results in mitochondrial fragmentation and affects chlamydial growth. Bars, 10 µm. Yellow box and inset point out the damaged mitochondrial architecture. (D) Quantification of chlamydial inclusion in induced and noninduced samples infected with *C. trachomatis* for 24 h. The samples were stained against cHSP60 (Cy3, 570 nm), and MitoTracker Deep Red FM was used to label the mitochondria. The number of inclusions was quantified using Object Count; ∼600 cells were analyzed from a random selection of six regions of interest (ROIs)/sample; *n* = 3. (E and F) Graphs represent the analysis of mitochondrial fragment length distribution and number of individual mitochondrial fragments in noninduced and AHT-induced miR-30c sponge cells. *n* = 6; ∼20 cells were analyzed from a random selection of ∼10 ROIs in each sample. Immunoblot of chimeric GFP protein under the control of the wild-type p53 3′ UTR (G) and mutant p53 3′ UTR (H). Blots were probed with antibodies against GFP, cHSP60, dsRed, and β-actin. (I) Quantification of chimeric GFP expression normalized to the expression of the dsRed transfection control (*n* = 3). All data represent mean ± SD. Asterisks denote significance by Student's *t* test: \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001. See also Fig. S1.](JCB_201608063_Fig2){#fig2}

We have previously shown that *C. trachomatis* infection in HUVECs results in a dramatic down-regulation of the tumor suppressor p53 in a phosphoinositide 3 kinase--Akt--dependent manner via HDM2 regulation ([@bib71]). We further tested whether chlamydial infection can regulate p53 in a miR-30c--dependent manner. We created GFP-based reporter constructs that carry the wild type p53 3′ UTR or the p53 3′ UTR in which the miR-30c binding site was altered. *C. trachomatis* infection of HUVECs transfected with the reporter construct down-regulated the levels of GFP under the control of the wild-type p53 3′ UTR, whereas the levels of GFP under the control of the mutated 3′ UTR remained unchanged ([Fig. 2, G--I](#fig2){ref-type="fig"}). Our results show that *C. trachomatis--*induced down-regulation of the host p53 is not dependent solely on the E3 ligase activity of HDM2, but depends also on the regulation of p53 mRNA by miR-30c.

Down-regulation of p53 during *C. trachomatis* infection is a prerequisite for normal chlamydial development ([@bib71]). Therefore, it is very likely that the strong interference of miR-30c down-regulation on chlamydial development ([Fig. 2, A--D](#fig2){ref-type="fig"}) depends on the stabilization of p53 resulting from the reduction in miR-30c abundance (Fig. S1, G--I). Additionally, modulation of miR-30c had noticeable effects on the mitochondrial architecture of both HUVECs and HeLa cells.

*C. trachomatis* infection reduces Drp1 protein levels and inhibits accumulation of Drp1 aggregates on the mitochondrial surface {#s04}
--------------------------------------------------------------------------------------------------------------------------------

The cellular mitochondrial network is greatly influenced by the general metabolic health of the cell ([@bib11]; [@bib38]). A cell stressed with increased energy demand will exhibit hyperfused mitochondria ([@bib26]; [@bib62]), whereas fission is necessary for quality control and degradation of damaged organelles ([@bib81]). The delicate balance between fusion and fission of mitochondrial fragments is maintained by a dedicated group of cytoplasmic and mitochondrial proteins, which in turn are regulated by immune response pathways ([@bib34]), cellular stress ([@bib10]; [@bib35]), oxidative stress ([@bib59]), and miRNAs ([@bib84]; [@bib76]). Dynamin-related protein 1 (Drp1) is one such cytoplasmic GTPase protein that functions as a master regulator of mitochondrial fission ([@bib73]). Several groups have studied the regulation of Drp1 in depth ([@bib14]; [@bib36]; [@bib9]). Recently, it has come to light that miRNAs also influence the fission-inducing activity of Drp1 via modulation of the tumor suppressor protein p53 ([@bib42]; [@bib84]). Both p53 and Drp1 have pivotal roles in mitochondrial regulation of apoptosis ([@bib26]), and Drp1-dependent mitochondrial remodeling is a crucial step for induction of apoptosis ([@bib44]).

Overexpression of miR-30c and p53 suppression can reduce disease-associated mitochondrial fragmentation by inhibiting the transcription of Drp1 in specific cell types ([@bib42]). Additionally, p53 is reported to induce Drp1 translocation to the mitochondrial surface by suppression of miR-499 expression, which in turn regulates the expression of the Drp1 activator, calcineurin ([@bib84]). Thus, we determined whether *C. trachomatis* infection affects the levels of Drp1 in HUVECs. *C. trachomatis*--infected HUVECs exhibit decreased levels of Drp1 mRNA and protein 24 and 36 h after infection. Correspondingly, the amount of p53 mRNA changes as well ([Fig. 3, A and B](#fig3){ref-type="fig"}). Similar changes in the protein levels of Drp1 were also observed in hFIMB cells ([Fig. 3 C](#fig3){ref-type="fig"}). This observation corresponds to the *C. trachomatis*--induced up-regulation of miR-30c ([Fig. 1, B--E](#fig1){ref-type="fig"}) and down-regulation of p53 expression ([Fig. 2 A](#fig2){ref-type="fig"}). Overexpression of Drp1 almost completely abrogated *C. trachomatis* growth in HUVECs ([Fig. 3 B](#fig3){ref-type="fig"}). Consistent with the previous observations, targeted down-regulation of Drp1 in HeLa cells and HUVECs enhances chlamydial growth and production of infectious progeny ([Fig. 3, D--F](#fig3){ref-type="fig"}, and Fig. S2 A), Furthermore, Operetta-based high-throughput characterization of chlamydial inclusion in cells with overexpression or knockdown of Drp1 revealed significant differences in inclusion size. Although *C. trachomatis* was barely able to establish infection in cells expressing enhanced levels of DRP1, the inclusions in DRP1 siRNA-transfected cells were significantly bigger compared with control (Fig. S2, B and C)

![***C. trachomatis* infection reduces Drp1 protein levels upon infection and is affected by artificial modulation of Drp1 levels.** (A) Quantification of qRT-PCR for p53 and Drp1 mRNA levels in noninfected and *C. trachomatis* (C.tr)--infected HUVECs for 12, 24, and 36 h. Fold change of Drp1 (± SD) at 24 h, 0.6 ± 0.30; and 36 h, 0.325 ± 0.10 (*n* = 6). (B) Immunoblot of HUVECs transfected with vector control or pcDNA-Drp1 overexpression vector and infected with *C. trachomatis* for 12, 24, and 36 h. Blots were probed with antibodies against Drp1, chlamydial heat shock protein 60 (cHSP60), and actin. (C) Immunoblot of hFIMB cells infected with *C. trachomatis* for 12, 24, and 36 h. Blots were probed with antibodies against Drp1, cHSP60, and actin. (D) Immunoblot of HeLa cells transfected with siRNA negative control and Drp1 siRNA infected with *C. trachomatis* for 12, 24, and 36 h. Blots were probed with antibodies against Drp1, cHSP60, and actin. (E) Immunoblot of HUVECs transfected with siRNA negative control or siRNA against Drp1 for 24 h and infected with *C. trachomatis* for 18 h. Blots were probed with antibodies against Drp1, cHSP60, and actin. (F) Immunoblot of infectivity assays of 36 h of primary *C. trachomatis* infection in HUVECs transfected with siRNA negative control, pcDNA-Drp1 overexpression vector, or Drp1 siRNA pool. All data represents mean ± SD. Asterisks denote significance by Student's *t* test. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, nonsignificant.](JCB_201608063_Fig3){#fig3}

Drp1 undergoes extensive posttranslational modifications such as phosphorylation ([@bib14]), *S*-nitrosylation ([@bib29]), ubiquitination ([@bib36]), and SUMOylation ([@bib9]), which govern its translocation to the mitochondrial surface and capacity to form ring-like aggregates. Using superresolution structured illumination microscopy (SR-SIM), we plotted the intensity profiles of mitochondrial fragments and Drp1 to identify mitochondrial fission sites. Using the intensity profiles, we determined the presence of Drp1 aggregates on regions of the mitochondria exhibiting constrictions ([Fig. 4 A](#fig4){ref-type="fig"}). Quantification of the number of Drp1 aggregates on the surface of the GFP-tagged mitochondria of uninfected and *C. trachomatis*--infected HUVECs (mito-HUVECs) revealed a reduction in the number of Drp1 aggregates in the infected cells ([Fig. 4, B--D](#fig4){ref-type="fig"}). Furthermore, quantification of constricted and dilated Drp1 rings in control and *C. trachomatis*--infected cells showed that infected cells had reduced instances of both (Fig. S2, D and E).

![***C. trachomatis* infection inhibits accumulation of Drp1 aggregates on the mitochondrial surface.** (A) Graph represents fluorescence intensity profile plot of a mitochondrial fragment (green) with Drp1 aggregates (red) on constriction sites (magenta arrowheads). The number of Drp1 aggregates was quantified, and intensities in both channels were measured along the depicted axis (white line in the last panel through the fragment). Bars, 1 µm. (B) Structured illumination micrographs of mito-HUVECs infected with *C. trachomatis* (C.tr; stained against cHSP60; Cy3), treated with 1 µM H~2~O~2~ for 1 h, or treated with 1 µM H~2~O~2~ for 1 h after 24 h of *C. trachomatis* infection. The samples were probed against Drp1 and stained with Atto647N. Bars, 10 µm. Zoomed insets (yellow boxes) show DRP 1 aggregation at mitochondrial constriction sites. Bars, 1 µm. (C and D) Quantification of Drp1 aggregates (sizes 100 to 280 nm) in *C. trachomatis*--infected and uninfected HUVECs. Indicated samples were treated with 1 µM H~2~O~2~ for 1 h or treated with 1 µM H~2~O~2~ for 1 h after 24 h of *C. trachomatis* infection. Number of Drp1 aggregates per cell (± SD) for noninfected and infected cells was 377.2 ± 65.86 and 251.8 ± 46.44 (∼60 cells were analyzed from random selection of 20 regions of interest \[ROIs\] in each sample). 2 or 3 random 10 × 10-µm ROIs were chosen in each selected cell. Significance was determined by Mann--Whitney test; *n* = 10). (C and E) Structured illumination micrographs and graph represent colocalization analysis (Pearson's coefficient) between Drp1 and mitochondrial GFP using the COLOC2 plugin; ∼20 cells were analyzed per sample. 2 or 3 random 10 × 10-µm ROIs were chosen in each selected cell. *n* = 10). Bars, 2 µm. All data represent mean ± SD. Asterisks denote significance by Student's *t* test. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, nonsignificant. See also Figs. S2 and S3.](JCB_201608063_Fig4){#fig4}

Additionally, comparison of the degree of colocalization of the Drp1 aggregates with mitochondria between *C. trachomatis*--infected and noninfected HUVECs showed a marked decrease in the presence of Drp1 aggregates on the mitochondrial surface of *C. trachomatis*--infected cells ([Fig. 4, D and E](#fig4){ref-type="fig"}). Treatment with cobalt chloride (CoCl~2~) and hydrogen peroxide (H~2~O~2~) does not significantly increase the abundance of Drp1 aggregates or colocalization with mitochondria in *C. trachomatis*--infected cells ([Fig. 4, C--E](#fig4){ref-type="fig"}). CoCl~2~ acts by inducing a reactive oxygen species (ROS)-mediated up-regulation of p53 expression, whereas H~2~O~2~, in addition to p53 up-regulation, depletes the miR-30 family, leading to an eventual up-regulation of Drp1-mediated mitochondrial fission ([@bib4]; [@bib42]). However, upon treatment with H~2~O~2~, the levels of miR-30c remained unchanged in *C. trachomatis*--infected HUVECs, and levels of p53 remained down-regulated (Fig. S2, F and G). This supports an essential role of maintaining high miR-30c levels in infected cells even under ROS stress.

Drp1 has been shown to form ring-like aggregates on the mitochondrial surface, which cause outer mitochondrial membrane scission in a GTP-dependent conformational change of the ring diameter ([@bib32]; [@bib50]; [@bib66]). Overexpression of Drp1 induced massive mitochondrial fragmentation and inhibited chlamydial infection not only in HUVECs ([Fig. 3 B](#fig3){ref-type="fig"}; and [Fig. 5, A--C](#fig5){ref-type="fig"}) but also in H1299 p53^−/−^ cells ([Fig. 5, D--H](#fig5){ref-type="fig"}), demonstrating that Drp1 can induce fission and inhibit *C. trachomatis* even in the absence of p53. However, this inhibitory effect of DRP1 on the growth and development of *C. trachomatis* was not observed when H1299 p53^−/−^ cells were transfected with a catalytically inactive and dominant negative variant of DRP1 (DRP1~K38A~; [@bib72]), which fails to induce and inhibits successful mitochondrial fission events ([Fig. 5, E--H](#fig5){ref-type="fig"}). Interestingly, *C. trachomatis* infection had no significant effect on the mitochondrial length of H1299 cells, possibly because of the lack of p53.

![**Functional Drp1 overexpression in a p53-null background fragments mitochondria and inhibits *C. trachomatis* infection.** (A) Structured illumination micrograph of mito-HUVECs infected with *C. trachomatis* (C.tr) for 24 h, transfected with pcDNA-Drp1 overexpression vector, or both. Graphs represent quantification of mitochondrial length and the number of mitochondrial fragments in HUVECs upon *C. trachomatis* infection, overexpression of Drp1, or both. Bars, 10 µm. (B) Analysis of mitochondrial fragment length distribution in HUVECs infected with *C. trachomatis* and transfected with Drp1 overexpression vector. Dots represent the mean mitochondrial fragment length of ∼3 cells in a region of interest (ROI) chosen at random within samples. 30 such dots were plotted on the graph. Mean mitochondrial fragment length (μm; ± SD) in control, 6.25 ± 0.66; *C. trachomatis* (24 h), 12.08 ± 0.87; Drp1 overexpression, 1.39 ± 0.74; and Drp1 overexpression + *C. trachomatis* (24 h), 2.3 ± 1.02. (C) Analysis of mitochondrial fragment count in HUVECs infected with *C. trachomatis* and transfected with Drp1 overexpression vector. Mean mitochondrial fragment count (± SD) in control, 240 ± 30.08; *C. trachomatis* (24 h), 133 ± 44.31; Drp1 overexpression, 388 ± 51.69; and DRP1 overexpression + *C. trachomatis* (24 h), 399 ± 58.58 (*n = 3* for B and C; ∼30 cells were analyzed from random selection of ∼10 ROI in each sample). (D and E) Immunoblots for different durations of *C. trachomatis* infection in control H1299 p53^−/−^ cells and H1299 p53^−/−^ cells transfected with pcDNA-Drp1 overexpression vector or dominant negative variant of Drp1-Drp1~K38A~ ([@bib73]). Blots were probed for Drp1, p53, cHSP60, and β-actin (*n = 3*). (F) Structured illumination micrograph of H1299 p53^−/−^ cells expressing GFP targeted to mitochondria. Samples were transfected with pcDNA-Drp1 overexpression vector or DRP1~K38A~ and infected with *C. trachomatis* for 24 h. Bars, 10 µm. (G) Graph represents quantification of the mitochondrial length distribution in H1299 p53^−/−^ cells upon *C. trachomatis* infection and overexpression of Drp1 or Drp1~K38A~ before infection. Dots represent the mean mitochondrial fragment length of ∼3 cells in an ROI chosen at random within samples. 30 such dots were plotted on the graph. Mean mitochondrial fragment length (μm; ± SD) in control, 5.59 ± 1.24; *C. trachomatis*, 5.69 ± 0.78; DRP1 overexpression, 2.21 ± 0.83; Drp1 overexpression + *C. trachomatis* (24 h), 1.72 ± 0.73; Drp1~K38A~ overexpression, 6.18 ± 0.95; and DRP1 K38 overexpression + *C. trachomatis* (24 h), 6.33 ± 0.82. (H) Analysis of mitochondrial fragment count in H1299 p53^−/−^ cells upon *C. trachomatis* infection, overexpression of Drp1 or DRP1~K38A~ before infection. Mean mitochondrial fragment count (± SD) in control, 121.31 ± 27.56; *C. trachomatis*, 130.56 ± 25.56; DRP1 Overexpression = 225.87 ± 29.63; Drp1 overexpression + *C. trachomatis* (24 h), 233.43 ± 32.45; Drp1~K38A~ overexpression, 119.12 ± 32.45; and Drp1~K38A~ overexpression + *C. trachomatis* infection (24 h), 128 ± 22.96 (*n = 3* for panels G and H; ∼30 cells were analyzed from random selection of ∼10 ROIs in each sample). All data represent mean ± SD. Asterisks denote significance by one-way analysis of variance followed by Tukey's multiple comparisons test for panel C and panel D: \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, nonsignificant.](JCB_201608063_Fig5){#fig5}

Similarly to the effect of Drp1 overexpression on *C. trachomatis* in H1299 p53^−/−^ cells, overexpression of p53 pre- and postinfection also has an inhibitory effect on *C. trachomatis* growth. Additionally, forced overexpression of p53 increases both Drp1 expression and its mitochondrial localization in H1299 p53^−/−^ cells (Fig. S3, A--F).

Thus, we argue that *C. trachomatis*--induced up-regulation of miR-30c diminishes p53 expression and, as a result, reduces expression and accumulation of functional Drp1 on the mitochondrial surface. Defects in Drp1 have been shown to result in hyperfused mitochondria and resistance to mitochondrial fragmentation and apoptosis ([@bib60]; [@bib77]). Collectively, our observations corroborate the previously known fact that *C. trachomatis* can inhibit apoptosis in HUVECs by down-regulating p53 ([@bib71]) and imply that *C. trachomatis* infection affects mitochondrial fission in the host via p53-mediated down-regulation of Drp1.

*C. trachomatis* infection modulates ROS production within the mitochondrial matrix {#s05}
-----------------------------------------------------------------------------------

It has been reported that *C. trachomatis* induces ROS production upon infection ([@bib7]), but the effect of such an event on mitochondria and the mitochondrial matrix has not been studied. We measured the effect of *C. trachomatis* infection on the mitochondrial matrix using a Timer protein targeted to mitochondria by fusing the mitochondrial targeting sequence of the human cytochrome c oxidase subunit VIII (*Cox8*) gene (MitoTimer; [@bib39]). MitoTimer exhibits a shift in fluorescence spectrum (500 to 596 nm) upon encountering ROS. We transiently expressed the MitoTimer protein in HUVECs and HFF cells and confirmed the localization in the mitochondrial matrix (Fig. S4, A and B). The expression of MitoTimer is observable 8 h after transfection as a green fluorescence (unoxidized form). The protein eventually matures to red (oxidized form), which can be prevented to an extent by washing and exchanging medium every 4 h ([Fig. 6 A](#fig6){ref-type="fig"}). Although the MitoTimer protein has previously been used to exhibit protein turnover in mitochondria and equilibration of mitochondrial protein age ([@bib19]), other studies have shown the susceptibility of MitoTimer to oxidative stress ([@bib39]). To confirm this observation, we performed live-cell imaging with MitoTimer-transfected HUVECs in the presence and absence of 5 µM H~2~O~2~. Upon H~2~O~2~ treatment, MitoTimer was found in its oxidized form ([Fig. 6, A--D](#fig6){ref-type="fig"}; and Videos 1 and 2), which is consistent with the effect of H~2~O~2~ to create oxidative stress within the mitochondrial matrix. HUVECs transfected with MitoTimer were infected with *C. trachomatis*, and the shift in fluorescence spectrum was measured by quantifying the percentage of cells expressing the red oxidized form of MitoTimer by flow cytometry. We observed that 8 h after infection, there is a significant increase in the population of cells exhibiting the red variant of MitoTimer within the mitochondrial matrix; 16 h after infection, however, this effect is reversed and the population of cells expressing the red variant of MitoTimer is reduced significantly. There is a second peak of fluorescence shift at 24 h after infection, during which ∼44% (± 3.8%; ± SD) of the cells begin to exhibit the red variant of MitoTimer. This population gradually reaches a plateau phase after 24 h. By that time, ∼10% of the noninfected HUVECs begin exhibiting red fluorescence within the mitochondrial matrix ([Fig. 6, E and F](#fig6){ref-type="fig"}) possibly because of the accumulation of metabolites. Similar effects were also observed in MitoTimer-transfected HFF cells ([Fig. 6, E and G](#fig6){ref-type="fig"}). Interestingly, treatment of HUVECs with 1 µM H~2~O~2~ 30 min before *C. trachomatis* infection does not significantly alter the fluorescence shift pattern upon infection, whereas such treatment in uninfected cells results in a dramatic increase in cell populations expressing the red variant of Timer with time. *C. trachomatis*--infected cells can also resist the H~2~O~2~-induced down-regulation of miR-30c and up-regulation of p53 (Fig. S2, F and G).

![***C. trachomatis* infection modulates ROS production within the mitochondrial matrix.** (A) Micrographs represent start (*t* = 0 min) and endpoints (*t* = 30 min) of Videos 1 and 2. pcDNA-MitoTimer was transfected into HUVECs, and the mitochondrial localization was ascertained by confocal laser scanning microscopy after 12 h. Bars, 10 µm. The samples were imaged simultaneously at 500 nm (green; native, unoxidized form) and 596 nm (red; oxidized form) to detect the fluorescence shift. 5 µM H~2~O~2~ was added into imaging media of indicated samples after 2 min of untreated imaging. Insets show the red channel images of the H~2~O~2~ -treated cells at *t* = 0 and 30 min. Images were captured every 60 s for 30 min. (B and C) Graphs indicate the change in fluorescent properties of the Timer protein in the absence and presence of H~2~O~2~ treatment. The arbitrary fluorescent intensity values were normalized to the starting fluorescent intensity value of the Timer protein in the green channel and depicted as percentage of that value. (D) Scatterplots indicate the change in fluorescent properties of the Timer protein in the absence and presence of H~2~O~2~ treatment as determined by FACS. Graphs indicate the percentages of cell population that exhibit fluorescence in the red channel (red box). (E) Scatter plots of MitoTimer transfected HUVEC and HFF cells after *C. trachomatis* (C.tr) infection for 8, 16, 24, and 36 h. A second group of cells were pretreated with 5 µM H~2~O~2~ for 30 min, washed, and infected with *C. trachomatis* for 8, 16, 24, and 36 h. Finally, as a control, HUVEC and HFF cells were treated with 5 µM H~2~O~2~ for 30 min, washed, and allowed to grow for 8, 16, 24, and 36 h. All samples were transfected 12 h before infection or treatment. The red box indicates the fraction of cell population expressing the red MitoTimer. (F and G) Graphs indicate the percentages of HUVEC and HFF cell populations that exhibit fluorescence in the red channel after treatments (*n = 3*). All data represent mean ± SD. Asterisks denote significance by Student's *t* test. \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, nonsignificant. See also Videos 1 and 2.](JCB_201608063_Fig6){#fig6}

We next transfected MitoTimer-expressing HUVECs with p53 and DRP1 siRNAs (separately) and treated them with 5 µM H~2~O~2~. Although siRNA-mediated knockdown of p53 and DRP1 did not have significant effects on the percentage of cells expressing the red variant of MitoTimer, the samples of HUVECs transfected with both p53 and DRP1 siRNAs and treated with 5 µM H~2~O~2~ exhibited significantly lower percentages of cells expressing the oxidized variant of MitoTimer (Fig. S4, C and D).

In conclusion, our data show that *C. trachomatis* infection reversibly induces stress within the mitochondrial matrix and at the same time provides protection from external sources of oxidative stress. This protection could be partially attributed to the down-regulation of p53 and Drp1 upon infection.

*C. trachomatis* infection induces changes in the mitochondrial architecture by inhibiting fragmentation {#s06}
--------------------------------------------------------------------------------------------------------

To gauge the extent to which *C. trachomatis* affects the mitochondrial morphology of the host, we studied the changes in mitochondrial morphology in *C. trachomatis*--infected mito-HUVECs after H~2~O~2~ treatment by SR-SIM ([Fig. 7 A](#fig7){ref-type="fig"}). Comparison of the mitochondrial fragment distribution and total mitochondrial area between noninfected and *C. trachomatis*--infected mito-HUVECs showed that infected cells exhibited mitochondrial phenotypes similar to those in Drp1 siRNA--transfected cells with elongated and hyperfused mitochondria ([Fig. 7, B and C](#fig7){ref-type="fig"}). *C. trachomatis* infection decreased the occurrence of isolated mitochondrial fragments, while simultaneously increasing the overall connectivity and length of the mitochondrial fragments. Whereas treatment with 1 µM H~2~O~2~ for 1 h increased fragmentation in uninfected cells, *C. trachomatis*--infected cells were resistant to such profragmentation stress ([Fig. 7, A--D](#fig7){ref-type="fig"}).

![***C. trachomatis* infection induces changes in the mitochondrial architecture by inhibiting fragmentation.** (A) Structured Illumination micrographs of mito-HUVECs posttreated with 1 µM H~2~O~2~ for 1 h after 12, 24, and 30 h of *C. trachomatis* (C.tr) infection (*C. trachomatis* stained with Alexa Fluor 647 against cHSP60 and DAPI to mark the nucleus). Bar, 10 µm. Red-bordered insets focus on uninfected cells, and yellow-bordered insets focus on infected cells. Bar, 1.5 µm. (B) Micrographs represent data processing and mitochondrial segmentation by rolling ball thresholding and 3D object count. Bars, 10 µm. (C) Analysis of mitochondrial fragment length distribution in cells treated with 1 µM H~2~O~2~ and infected with *C. trachomatis*. Dots represent the mean mitochondrial fragment length of approximately three cells in a region of interest (ROI) chosen at random within samples. 200 such dots were plotted on the graph. Mean mitochondrial fragments length in control (± SD), 7.607 ± 2.39; H~2~O~2~, 2.36 ± 1.06; *C. trachomatis*, 10.98 ± 2.05; and *C. trachomatis* + H~2~O~2~, 9.90 ± 1.84 (*n* = 20; ∼30 cells were analyzed from random selection of ∼10 ROIs in each sample). (D) Comparison of fragment distribution between infected and noninfected cells. Treatment with 1 µM H~2~O~2~ is taken as positive control for fragmentation, and 36 h of siRNA-mediated Drp1 knockdown is used as negative control. Number of fragments in control (± SD), 235.4 ± 36.34; H~2~O~2~, 414.6 ± 50.39; *C. trachomatis*, 169.1 ± 41.12; and *C. trachomatis* + H~2~O~2~, 198 ± 61.52 (*n = 20* for C and D; ∼30 cells were analyzed from random selection of ∼10 ROIs in each sample). (E) Freeze-frame of 20 × 20-µm sections of uninfected and *C. trachomatis*--infected mito-HUVECs from time-lapse video micrographs at *t* = 0 and 306 s (Videos 3--6). Indicated samples were treated with 1 µM H~2~O~2~. White bars represent 5 µm. Yellow bars (0.5 µm in thickness) represent arbitrary lines drawn to determine lateral displacement of mitochondrial fragments with time as represented by the Kymograph panels (unquantified). (F) Graph represents differences in mitochondrial mobility between HUVECs after 36 h of *C. trachomatis* infection, 1 µM H~2~O~2~ treatment for 1 h, or treatment with 1 µM H~2~O~2~ after 36 h of *C. trachomatis* infection. The distance moved by the mitochondrial fragments in 5 min was determined by analyzing Videos 3--6 with the mitoCRWLR macro (*n* = 5; three ROIs were analyzed from individual cells, with six cells being chosen at random from every sample). All data represent mean ± SD. Asterisks denote significance by one-way analysis of variance followed by Tukey's multiple comparisons test for C and D: \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001; ns, nonsignificant. See also Video 3--6.](JCB_201608063_Fig7){#fig7}

We also measured the rates of mitochondrial mobility using the novel macro script, mitoCRWLR (see Online supplemental material), because the changes in the rates of mitochondrial movement are largely governed by alterations in the fusion/fission ratio of the mitochondrial network ([@bib54]). Although H~2~O~2~ treatment of noninfected cells enhances mitochondrial fragmentation and random movements, *C. trachomatis*--infected cells were resistant to these changes ([Fig. 7, E and F](#fig7){ref-type="fig"}; and Videos 3, 4, 5, and 6).

To understand if the mitochondrial elongations seen in the *C. trachomatis*--infected cells were a result of increased number of fusion events or decreased fission events, we manually tracked segments of mitochondria within infected and noninfected cells for ∼3 h ([Fig. 8, A and B](#fig8){ref-type="fig"}; and Videos 7 and 8). We observed that, whereas infected cells exhibited a slight decrease in the occurrence of mitochondrial fusion, fission events were found to be quite rare. This reduced occurrence of fission events results in a slightly higher fusion/fission ratio in *C. trachomatis*--infected cells compared with noninfected controls, which favors elongation of the mitochondrial fragments ([Fig. 8 C](#fig8){ref-type="fig"}).

![**Changes in the mitochondrial fusion/fission ratio induce elongation of mitochondrial fragments in *C. trachomatis*--infected cells.** Montage of time-lapse confocal micrography of noninfected (A) and 24-h *C. trachomatis* (C.tr)--infected (B) HUVEC mitochondria (Videos 7 and 8). The samples were imaged for 3 h with pictures taken every 5 min. The purple arrowheads indicate fusion events, and the red arrowheads indicate fission events. Bars, 10 µm. (C) Graph represents differences in mitochondrial fusion/fission ratio between noninfected and *C. trachomatis*--infected samples. Fusion/fission ratio in control (± SD), 1.09 ± 0.22; and *C. trachomatis*, 1.58 ± 0.17 (*n* = 5; two regions of interest were analyzed from individual cells, with three cells being chosen at random from every sample). Asterisks denote significance by Student's *t* test. \*\*\*, P \< 0.001. See also Video 7.](JCB_201608063_Fig8){#fig8}

*C. trachomatis* infection is affected by regulation of ATP synthesis in the host mitochondria {#s07}
----------------------------------------------------------------------------------------------

Changes in mitochondrial morphology caused by aberrant fission/fusion ratios are among the earliest observable hallmarks of cellular stress ([@bib82]). An increasingly tubular nature of the mitochondrial network indicates a heightened requirement for oxidative phosphorylation ([@bib69]). Intracellular *C. trachomatis*, particularly the RBs, takes up ATP from the host cell ([@bib55]). This results in a drain on the cellular resources of ATP, and thus preservation of the mitochondrial network is essential for *C. trachomatis* to keep the available mitochondrial capacity for ATP production. In line with this hypothesis, we observed that depleting miR-30c severely affected ATP production and cell viability in HUVECs ([Fig. 9, A and B](#fig9){ref-type="fig"}). A similar decrease in ATP levels was also observed in induced HeLa-miR-30c sponge cells upon diminishing ATP production via glycolysis by growing the cells in galactose-containing medium ([Fig. 9 C](#fig9){ref-type="fig"}). Interestingly, overexpression of Drp1 and p53 lowers the ATP levels of HeLa and H1299 p53^−/−^ cells by a narrow margin (Fig. S4, E and F). Conversely, although siRNA-mediated knockdown of p53 and DRP1 did not have a major effect on the ATP levels of untreated HUVECs, the transfection of p53 or Drp1 siRNAs (separately) significantly ameliorated the effect of 1 µM H~2~O~2~ treatment on the ATP levels compared with that of control cells (Fig. S4 G). These results suggest that even though Drp1, independently of p53, affects cell physiology by regulating mitochondrial fragmentation, reduction of both p53 and Drp1 expression can lower the depletion of ATP within when the cell is faced with external oxidative stress. To further investigate the role of mitochondrial ATP in chlamydial survival we generated a stable HeLa cell with AHT-inducible knockdown of the F~1~β subunit of the mitochondrial F~1~F~O~-ATPase. As a control, we used a cell line with an inducible knockdown of metaxin 2, a mitochondrial outer membrane protein, which is known not to affect mitochondrial morphology and protein levels within the time frame of the experiment ([@bib56]). Silencing the expression of the F~1~β subunit was efficient ([Fig. 9 D](#fig9){ref-type="fig"}) but had almost no effect on cell viability ([Fig. 9 E](#fig9){ref-type="fig"}), and only a mild effect was observed on cellular ATP levels, because tumor cells such as HeLa produce ATP mainly via glycolysis. However, inhibition of glycolysis by growing the cells in medium containing galactose ([@bib67]) for 8 h caused a strong depletion of ATP ([Fig. 9 F](#fig9){ref-type="fig"}) without affecting cell survival. Under these conditions, *C. trachomatis* growth was severely affected ([Fig. 9, G and H](#fig9){ref-type="fig"}). At the same time, the knockdown of metaxin 2 had no effect on ATP production, cell viability, or *C. trachomatis* growth ([Fig. 9, E--G](#fig9){ref-type="fig"}). These results indicate that mitochondrial ATP is an essential metabolite for normal chlamydial development.

![***C. trachomatis* infection is affected by regulation of ATP synthesis in the host mitochondria.** (A) Graph represents quantification of total endogenous ATP levels in HUVECs transfected with siRNA negative control miR-30c mimic and inhibitors. Indicated samples were incubated in glucose-free galactose-supplemented media and tested using a luminescent ATP detection kit according to the manufacturer's protocol. ATP luminescence was normalized to ATP levels of untreated and nontransfected cells grown in glucose medium. (B) Cell viability measurements of HUVECs transfected with siRNA negative control, miR-30c mimic, and inhibitors and grown in glucose medium. (C) Graph represents quantification of total endogenous ATP levels in noninduced and induced HeLa-miR-30c sponge cells grown in glucose-free galactose-supplemented media. ATP luminescence was normalized to ATP levels of noninduced cells grown in glucose medium. (D) Immunoblot of isolated mitochondria from noninduced and induced (AHT) *f1βkd-2* and *mtx2kd-2* cells. Blots were probed with antibodies against F~1~α subunit, and isocitrate dehydrogenase (ICDH) was used as a loading control. (E) Cell viability measurements of noninduced and induced *mtx2kd-2* and *f1βkd-2* cells incubated in glucose-containing medium or for 16 h in glucose followed by 8 h in galactose-supplemented medium. (F) Graph represents ATP measurements of *mtx2kd-2* and *f1βkd-2* cells. The cells were incubated in glucose-containing medium or for 16 h in glucose followed by 8 h in galactose-supplemented medium. ATP luminescence was normalized to ATP levels of noninduced cells grown in glucose medium. (G) Graph represents quantification of chlamydial inclusion sizes in noninduced and induced *mtx2kd-2* and *f1βkd-2* cells infected with *C. trachomatis* for 24 h in glucose-containing medium or for 16 h in glucose followed by 8 h in galactose-supplemented medium (*n* = 3). (H) Representative epifluorescence micrographs of noninduced and induced *f1βkd-2* cells infected with *C. trachomatis* for 24 h and treated as mentioned earlier and grown in glucose followed by 8 h in galactose-supplemented medium. Cells were stained against cHSP60 (magenta) and phalloidin-647 for actin (blue). GFP (green) indicates induction of shRNA. Bars, 10 µm. All data represent mean ± SD. Asterisks denote significance by Student's *t* test. \*, P \< 0.05; \*\*, P \< 0.01; \*\*\*, P \< 0.001 (*n = 3* for all panels). See also Fig. S4.](JCB_201608063_Fig9){#fig9}

Discussion {#s08}
==========

Obligate intracellular pathogens such as *C. trachomatis* necessitate the survival of the host to ensure the availability of the metabolites required for the completion of the developmental cycle. Noting the lack of several key metabolic pathway components in its genome, *C. trachomatis* is heavily influenced by host metabolic conditions and particularly sensitive to the perturbations that interfere with the production and availability of amino acids, nucleotides, and lipids ([@bib68]). Previous studies show that *C. trachomatis* requires the production of ROS for normal development ([@bib7]; [@bib13]; [@bib71]). Our data further show that *C. trachomatis* infection results in reversible stress on the host mitochondrial network. Normally, the presence of such stress factors would induce an overall negative effect on host mitochondrial health, leading to rapid fragmentation and induction of apoptotic pathways. However, our study and previous evidence show that the mitochondrial damage and pro-apoptotic effects of oxidative damage can be ameliorated to a degree by suppressing the activity or expression of the p53-dependent mitochondrial fission regulator Drp1 ([@bib12]; [@bib53]). Here we show that *C. trachomatis* infection, in addition to HDM2-induced degradation of p53, up-regulates miR-30c within infected cells to down-regulate p53 and suppress Drp1 expression.

Our data show that the down-regulation of Drp1 upon *C. trachomatis* has a significant effect on the host mitochondria as exhibited by the elongated and fused nature of the network, a hallmark of cells that are facing increased energy demand ([@bib79]). Furthermore, we show that enforced mitochondrial fission by Drp1 overexpression in the absence of p53 also prevents chlamydial development, highlighting the need for Drp1 suppression. Additionally, it has been shown that Drp1 stabilization negatively affects intracellular ATP levels as a result of excessive mitochondrial fragmentation ([@bib65]), which makes the reduction of Drp1 activity indispensable for *C. trachomatis* growth. Interestingly, new evidence has shown that IFNγ-induced autophagy inhibits *C. trachomatis* growth ([@bib3]). In context of the increased demand for metabolites and amino acids during *C. trachomatis* growth and development, resulting in a crippling nutrient-deprived (amino acids, ATP, and glucose) state for the host cell, it is interesting to note that loss of DRP1 possibly prevents the necessary mitochondrial fission that precedes mitophagy ([@bib80]). Furthermore, mild oxidative stress, akin to the sort generated by *C. trachomatis* infection, although incapable of inducing cell death or nonselective autophagy, is capable of inducing mitochondrial fragmentation and mitophagy ([@bib23]). [@bib23] also demonstrate that induction of mitophagy by such stress and by starvation can be inhibited by inhibition of DRP1 function. Additionally, it has been shown that elongated mitochondria are not only capable of maintaining ATP levels during nutrient deprivation but are also selectively spared from autophagic degradation ([@bib26]; [@bib62]). It is hard to tell at this stage, however, whether it is the loss of DRP1 that restricts the induction of autophagy during the *C. trachomatis* growth-induced nutrient stress.

For intracellular bacteria such as *C. trachomatis*, survival of the host and maintenance of the metabolite supply is of paramount importance. Therefore, we suggest that the down-regulation of Drp1 in a miR-30c/p53--dependent manner serves to stabilize the mitochondrial network to maintain the metabolic integrity of the host cell in the presence of the severe stress caused by *C. trachomatis* infection ([Fig. 10](#fig10){ref-type="fig"}). This is a unique example of a mechanism by which an intracellular pathogen influences the host mitochondrial network by deregulation of a miRNA.

![**Model of the effects of *C. trachomatis* on the mitochondrial network.** Graphical representation of the effect of *C. trachomatis* infection on the mitochondrial network via miR-30c--mediated regulation of p53 and Drp1.](JCB_201608063_Fig10){#fig10}

Materials and methods {#s09}
=====================

Reagents and antibodies {#s10}
-----------------------

Antibodies against cHSP60 (A57-B9), p53 (DO-1), GFP (B-2), and caspase-3 were purchased from Santa Cruz Biotechnology, Inc. Rabbit polyclonal anti-Drp1 was purchased from Genetex. Mouse monoclonal anti-Drp1 antibody (C-5) used for immunoblots was purchased from Santa Cruz Biotechnology, Inc. Equal loading was confirmed by using antibodies against β-actin (A5441; Sigma-Aldrich). Anti--mouse and anti--rabbit IgG Cy3TM- or Cy5TM-linked goat secondary antibodies were purchased from Dianova. All oligonucleotides used for real-time PCR, cloning and Northern blots were purchased from Sigma-Aldrich. FlexiTube GeneSolution (GS10059; QIAGEN) was used for siRNA knockdown of Drp1 and p53. Syn-hsa-miR-30c-5p miScript miRNA Mimic (MSY0000244), anti--hsa-miR-30c-5p miScript miRNA inhibitor (MIN0000244)and AllStars negative control siRNA were purchased from QIAGEN. MitoTracker Deep Red FM was purchased from Thermo Fisher Scientific. All buffers and reagents were purchased from Sigma-Aldrich unless otherwise mentioned.

Cell culture {#s11}
------------

HUVECs were cultured in Medium 200 supplemented with low serum growth supplement (Gibco) at 37°C in 5.0% CO~2~ unless otherwise mentioned. HeLa229, HeLa-miR-30c sponge cells, *f1βkd-2*, and *mtx2kd-2* cells were cultured in RPMI-1640 medium supplemented with 10% FCS (Gibco) at 37°C in 5.0% CO~2~ unless otherwise mentioned. HFF cells were cultured in fibroblast basal medium (Gibco) supplemented as per manufacturer recommendation. hFIMB cells were prepared ([@bib8]) and cultured in RPMI-1640 medium supplemented with 10% FCS (Gibco) at 37°C in 5.0% CO~2~. The use of the cells was in accordance with the guidelines imposed by the local ethics committee.

Propagation of *C. trachomatis* and infection of cells {#s12}
------------------------------------------------------

HeLa cells infected with *C. trachomatis* LGV serovar L2 and *C. trachomatis* serovar D (ATCC) for 48 h were collected with a rubber policeman, transferred to a 50-ml tube, and lysed by vortexing with glass beads. To remove cell debris, the supernatant was centrifuged at 500 *g* at 4°C for 10 min (Hermle). To pellet down *C. trachomatis*, the supernatant was removed and centrifuged at 45,000 *g* for 45 min at 4°C in a SS34 rotor (Thermo Fisher Scientific). *C. trachomatis* was washed in SPG buffer (0.22 M sucrose, 10 mM Na~2~HPO~4~, 3.8 mM KH~2~PO~4~, and 5 mM glutamate, pH 7.4), aliquoted, and stored at −80°C.

For experiments, cells were infected with *C. trachomatis* with a multiplicity of infection of 1 in Medium 200 supplemented with low serum growth supplement (for HUVECs) and RPMI-1640 with 5% FCS (for HeLa) at 35°C for 2.5 h. The infected cells were incubated for necessary time periods. The cells were then processed for experiments as described. For [Fig. 4 A](#fig4){ref-type="fig"}, a multiplicity of infection of 0.6 was used to include noninfected cells in the imaging fields.

Infectivity assay {#s13}
-----------------

Infectivity assays for *C. trachomatis* were performed as described previously ([@bib71]). In brief, *C. trachomatis*--infected cells (36 hpi) and uninfected control cells were washed once with PBS and lysed manually by glass beads. A second set of cells was seeded the day before and infected by one-hundredth of the cell lysate containing infectious EBs, incubated for 12, 24, and 36 h at 35°C, and lysed for immunoblot analysis.

Transfection {#s14}
------------

All plasmid transfections in HUVECs and HFF cells were performed using Lipofectamine 2000 (Invitrogen) or X-tremeGENE HP DNA Transfection Reagent (Roche) according to the manufacturer's protocol. miR-30c mimic, miR-30c inhibitor, and Drp1 siRNA transfection in HUVECs was performed with RNAiFect Transfection Reagent (QIAGEN) for 24 h before infection or processing. Plasmid DNA constructs were transfected into HeLa229 cells using polyethylenimine according to the protocol published by [@bib43].

RNA sequencing of small RNA fraction {#s15}
------------------------------------

Total RNA, including the small RNA fraction, was extracted from HUVECs after 12 and 24 h of *C. trachomatis* infection along with noninfected samples (0, 12, and 24 h) using miRNAeasy kit (QIAGEN) according to the manufacturer's protocol. Vertis Biotechnology AG performed library preparation, and the RNA-sequencing was performed on an Illumina HiSeq 2000 sequencer at the Max Planck-Genome-centre Cologne, Cologne, Germany, as described in [@bib48].

Computational analysis of RNA-seq data {#s16}
--------------------------------------

RNA-seq analysis was performed using the READemption pipeline v0.3.3 ([@bib22]) with Segemehl v0.1.7 ([@bib57]) for the mapping of transcripts against human mature miRNA sequences obtained from miRBase ([@bib48]), the human and *C. trachomatis* genomes (NCBI references [NC_021049](NC_021049) and [NC_021052](NC_021052)). Parameter cutoffs of 14 nt as minimum read length and 95% as minimum similarity were used. Differential gene expression analysis was performed with DESeq 1.12.1 ([@bib5]) comparing infected samples to noninfected samples collected at the same time point. Pathway-based analysis of selected miRNAs was done with the DIANA-miRPath v2.0 web server ([@bib83]).

Designing of wild-type and mutant P53 3′ UTR {#s17}
--------------------------------------------

The human P53 full-length 3′ UTR was PCR-amplified from HUVECs using forward and reverse primers that introduced XhoI and NotI restriction sites at the 5′ and 3′ ends, respectively. The sequence of the primers used are as follows: forward, 5′-TAGAAT[TCTAGA]{.ul}CCCTAGGGGTCTTGGCCATTC-3′, and reverse, 5′--TAGAAT[GCGGCCGC]{.ul} GCAGTCAGACAGCTTCTTTATTTGACT-3′; underlined sequences are the Xho1 and NotI sites, respectively. The 943-bp PCR product was ligated in the Empty GFP plasmid to create the GFP-p53-wt 3′ UTR vector. The vector carries an additional dsRed expression cassette independent of the GFP promoter, unaffected by any UTR, and serves as a normalization control. GFP-p53-mut 3′ UTR construct was prepared by performing site-directed mutagenesis on the wild-type construct. The sequences of the primers used to mutate the miR-30c binding sites are as follows: forward, 5′-TCTTGCAGTTAAGGGTTA[GTTCACA]{.ul}ATCAGCCACATTCTAGGT-3′, and reverse, 3′-ACCTAGAATGTGGCTGAT[TGTGAAC]{.ul}TAACCCTTAACTGCAAGA-5′; underlined sequences denote the mutated miR-30c binding sites. Quick-change site-directed mutagenesis protocol was used to generate a point mutation in the miR-30c binding site. The oligonucleotides described carry a single nucleotide change compared with the wild-type binding site and were extended in a PCR reaction using Phusion polymerase (Thermo Fisher Scientific). The polymerase was inactivated by 5-min incubation at 80°C. The original template was digested with DpnI for 1 h at 37°C followed by an inactivation step at 80°C for 20 min. The presence of the desired mutation was verified by DNA sequencing (SeqLab, Gottingen, Germany). The mutated and wild-type vectors were transformed into and propagated in chemo-competent *Escherichia coli* XL1Blue.

Designing of presequence GFP, GFP-P53, and Drp1 overexpression construct {#s18}
------------------------------------------------------------------------

To construct a mitochondrially targeted GFP (mtGFP) expression plasmid, the *egfp* were amplified from the pEGFP-N1 vector (Takara Bio Inc.). This was cloned into a modified pcDNA3.1 vector downstream of the mitochondria targeting presequence to generate the necessary constructs. For the Drp1 overexpression vector, the Drp1 insert was amplified from HUVEC cDNA using the following primers: forward, 5′-TCAGGCGGCCGCAGCGCATGGCCTGCCGGGA-3′, and reverse, 5′-CTAGCTCGAGCTACTCTATACGGTTATGTTCCAAAG-3′. The product was ligated into an empty pcDNA3.1 vector.

To generate GFP-P53 fusion construct, P53 was amplified from the pCDNA3-HA-p53 ([@bib46]) and cloned into the pCDNA3 vector already containing a GFP gene, so the product represented a p53 fused with its amino terminus to the GFP, including two linker amino acids between the proteins originating from the EcoRI restriction site. pcDNA3-Drp1~K38A~ was a gift from A. van der Bliek (David Geffen School of Medicine at University of California, Los Angeles, South Los Angeles, CA) and R. Youle (National Institute of Neurological Disorders and Stroke, Porter Neuroscience Research Center, Bethesda, MD; plasmid 45161; Addgene). pMitoTimer was a gift from Z. Yan (University of Virginia, Charlottesville, VA; plasmid 52659; Addgene).

Designing of miR-30c sponge {#s19}
---------------------------

For miR30c sponge preparation, mature miRNA sequence of miR-30c was obtained from miRBase. Oligo sequences carrying six miR30c target sites (italicized) each carrying a two-nucleotide bulge (underlined) and a central unrelated loop (marked in bold) were synthesized (Sigma-Aldrich), annealed, and cloned into the pLV-THM vector using MluI and ClaI sites downstream of H1 promoter sequences. Large-scale preparation of DNA required for lentivirus particle formation was performed using the endotoxin-free plasmid Midi prep system (MACHEREY-NAGEL). miR-30c-oligo, 5′-CGCGTCCCC*CTGAGG[AT]{.ul}GTAGGATGTTTACA*TGA*CTGAGG[AT]{.ul}GTAGGATGTTTACA*AGCGG*CTGAGG[AT]{.ul}GTAGGATGTTTACA***CCCGGTGCATGACTAAGCTAGC***CTGAGGATGTAGG[AT]{.ul}GTTTACA*CGA*CTGAGG[AT]{.ul}GTAGGATGTTTACA*ACGCG*CTGAGG[AT]{.ul}GTAGGATGTTTACA*TTTTTGGAAAT-3′.

Generation of sponge, shRNA, and mitochondrial GFP cell lines {#s20}
-------------------------------------------------------------

The miR-30c sponge and shRNA-expressing vectors were constructed by cloning the necessary miR-30c sponge oligo and shRNA sequence into the pLVTHM vector. The constructs were verified by sequencing. The sequence of the F~1~β shRNA was as follows: 5′-GCAGAATCATGAATGTCATTG-3′. The inducible miR-30c sponge and F~1~β KD (*f1βkd-2*) cell lines were constructed as described previously ([@bib56]). In brief, the lentiviral construct, pLVTHM-tTR-KRAB-Red vector, was transduced into HeLa cells in presence of the cationic polymer, Polybrene (Sigma-Aldrich). Single-cell clones were sorted by selecting the cells for dsRed expression by flow cytometry using a BD FACS Aria III. One single-cell clone was used for infection with the miR-30c sponge and F~1~β KD shRNA-carrying virus. After allowing the cells to proliferate, single-cell clones were obtained by a second sorting step by selecting for expression of dsRed to avoid miR-30c depletion--induced cell defects or F~1~β deficiency--induced defects. For expression of the miR-30c sponge, the cells were cultivated in RPMI-1640 plus 10% FBS supplemented with 1 µg/ml AHT for 24 h. For expression of the F~1~β KD shRNA, the cells were cultivated in RPMI-1640 plus 10% FBS supplemented with 1 µg/ml AHT for 5 to 7 d. The sponge expression was confirmed by Western blot for miR-30c targets (Fig. S1, F and G). An inducible knockdown cell line for the mitochondrial outer membrane protein metaxin2 ([@bib56]) was used as a control for all experiments involving F~1~β KD cells. To detect the effect of AHT on chlamydial growth, HeLa cells were treated with 0.5, 1, and 1.5 µg/ml AHT followed by *C. trachomatis* infection for 24 h. Chlamydial growth was monitored by immunoblot (Fig. S1 K). HUVECs stably expressing the mitochondrial targeted GFP were created by cloning the mitochondrial targeted GFP into a pLVTHM vector and transducing the cells with the lentivirus as described earlier. pLVTHM and pLV-tTRKRAB-red was a gift from Didier Trono (plasmid 12250; Addgene).

cDNA preparation and qRT-PCR {#s21}
----------------------------

cDNA preparation and qRT-PCR for miRNA were performed using the miScript II RT kit and miScript SYBR Green PCR kit (QIAGEN) according to manufacturer's protocols. Custom-made primers for all the miRNAs studied was also bought from QIAGEN. cDNA preparation and qRT-PCR for p53 and Drp1 were performed using the RevertAid RT kit (Thermo Fisher Scientific) and PerfeCTa SYBR Green FastMix (Quanta Biosciences). Primers for qRT-PCR were as follows: Drp1 forward, 5′-GCGCTGATCCCGCGTCAT-3′, and reverse, 5′-CCGCACCCACTGTGTTGA-3′; p53 forward, 5′-TCAACAAGATGTTTTGCCAACTG-3′, and reverse, 5′-ATGTGCTGTGACTGACTGACTGCTT-3′; and GAPDH forward, 5′-CGTCTTCACCACCATGGAGAAGGC-3′, and reverse, 5′-AAGGCCATGCCAGTGAGCTTCCC-3′.

All qRT-PCRs of miRNAs were performed using the miScript PCR System (QIAGEN) or miRCURY LNA universal RT miRNA PCR (Exiqon) with specific forward primers or LNA primer sets for individual miRNAs (QIAGEN or Exiqon) and endogenous control, U6 SnRNA (QIAGEN or Exiqon). All experiments were performed on a StepOnePlus real-time PCR platform (Applied Biosystems) according to the manufacturer's protocol. Data were analyzed using StepOne Software v2.3 and GraphPad Prism v6.

Northern blot {#s22}
-------------

Northern blots for miR-30c were performed using oligonucleotide probes for miR-30c (5-GCTGAGAGTGTAGGATGTTTACA-3′) and U6 snRNA (5-CACGAATTTGCGTGTCATCCTT-3′) according to the protocol described by the Narry Kim Lab (<http://www.narrykim.org/en/protocols>). U6 snRNA was used as loading control for all experiments done in HUVECs. The chlamydial small RNA described as CtrR5 ([@bib2]) was used as a marker for *C. trachomatis* infection (5′-CAGCACCCCTCTGAGTTCTCCC-3′). Hybond-XL (GE Healthcare) nylon membranes were used for Northern blots. Decade Markers System from Thermo Fisher Scientific was used to radiolabel RNA ladder for Northern blots.

Immunoblotting {#s23}
--------------

Infected or uninfected control cells were lysed in Laemmli sample buffer (100 mM Tris/HCl, pH 6.8, 4% SDS, 20% glycerin, 1.5% β-mercaptoethanol, and 0.2% bromophenol blue) and resolved by 12% SDS-PAGE. Proteins were transferred to PVDF membranes (EMD Millipore) and blocked with 5% milk/TBS-T. The membranes were probed with respective primary antibodies and subsequently with HRP-conjugated secondary antibodies. Proteins were detected by ECL (GE Healthcare) in the linear response range using an ECL Imager (Intas Science Imaging). β-Actin was used as loading control and for normalization in all cases unless stated otherwise.

Cell viability assay {#s24}
--------------------

Cells were plated in 96-well flat-bottom plates and transfected with the described constructs or siRNAs or treated with necessary reagents. At specific time points, 20 µl of 5 mg/ml MTT solution was added to the wells and incubated for 4 h. 170 µl DMSO was added after aspiration of media, and the absorbance (540 nm) was determined using an Infinite 200 PRO multimode reader (Tecan). Three technical replicate wells were used for each condition, and standard deviation was determined. Experiments were repeated three or more times, and statistical significance was calculated by unpaired *t* test.

Total ATP measurement {#s25}
---------------------

HUVECs, Hela-miR30c-sponge cells, or H1299 p53^−/−^ cells were plated in white-bottom 96-well plates for 12--24 h. The cells were incubated in necessary medium (glucose-free or galactose-supplemented) for indicated time periods after transfection or H~2~O~2~ treatment. Total endogenous ATP levels were measured using the Luminescent ATP Detection Assay kit (Abcam) according to the manufacturer's protocol. Three technical replicate wells were used for each condition, and standard deviation was determined. Experiments were repeated three or more times, and statistical significance was calculated by unpaired *t* test.

Flow cytometry {#s26}
--------------

HUVECs or HFF cells were seeded in six-well plates for 12 h and transfected with pMitoTimer for 24 h before infection or H~2~O~2~ treatment. Cells were washed every 4--6 h to prevent metabolite accumulation. At the endpoint, cells were trypsinized and suspended in cell-specific medium. The fluorescence of MitoTimer was measured simultaneously in FITC (509-nm) and PE (560-nm) channels by flow cytometry using a BD FACS Aria III.

Immunostaining and fixed-cell microscopy {#s27}
----------------------------------------

To visualize the mitochondrial division sites, HUVECs expressing GFP tagged with a mitochondrial presequence were stained with an anti--rabbit Atto-647N secondary antibody (Sigma-Aldrich) against the rabbit polyclonal anti-Drp1 antibody. Cells were seeded in 12-well plates on glass coverslips, transfected or treated with necessary constructs, siRNA, or reagents as required, and infected with *C. trachomatis* for the indicated times. Cells were washed in PBS and fixed with 4% PFA for 15 min. After washing, the cells were permeabilized using 0.2% Triton X-100 in PBS for 15 min and blocked with 2% FCS in PBS for 45 min. Cells were incubated for 1 h with the primary antibody in blocking buffer (2% FCS in PBS), washed three times in PBS, and stained with the corresponding secondary antibody. After three washes with PBS, a poststaining fixation process was performed for all samples imaged on the structured illumination platform. After a final wash with PBS, the samples were mounted onto slides using 2.5% Mowiol-DABCO (Carl Roth). Samples were imaged on a TCS SP5 confocal microscope (Leica Biosystems) using a 63× oil-immersion UV objective with a numerical aperture of 1.4. For superresolution imaging of Drp1 fission rings, images were acquired using a Zeiss ELYRA S.1 SR-SIM structured illumination platform using a Plan-Apochromat 63× oil-immersion objective with a numerical aperture of 1.4. The images were reconstructed using the ZEN 2012 image-processing platform with a SIM module.

Live-cell videomicroscopy {#s28}
-------------------------

In brief, HUVECs or H1299 cells were seeded 2 d before infection in µ-Dish 35-mm, high glass bottom (81158; Ibidi) to reach appropriate confluence. These cells were then transfected or treated with necessary constructs, siRNA, or reagents as required and infected with *C. trachomatis* for the indicated times. 10 min before imaging, cells were washed in PBS and bathed in prewarmed RPMI-1640 containing 25 mM Hepes buffer (without phenol red and Ca^2+^/Mg^2+^). The samples were imaged on a TCS SP5 confocal microscope (Leica Biosystems) using a 63× oil-immersion UV objective with a numerical aperture of 1.4 and equipped with a live-cell microscopy incubation chamber (Life Imaging Systems), prewarmed to 37°C. Images were collected on live cells using the Leica Biosystems Application Suite software package. Unless otherwise noted, 1,024 × 1,024-pixel images were recorded in 8-bit mode and collected at necessary time intervals.

Image analysis {#s29}
--------------

The surface area of inclusions relative to the cell surface for Fig. S2 (C and D) was determined via automated fluorescence microscopy as previously described ([@bib64]). All image-processing steps were performed using Fiji ([@bib70]). The numbers of *C. trachomatis* inclusions and Drp1 fission rings were quantified by processing the confocal micrographs with the Fiji Object Counter plugin after appropriate thresholding. Background was subtracted using the rolling ball background subtraction model. A threshold for detecting Drp1 aggregates was applied to the original micrographs by measuring the mean pixel intensity of the control samples in the Drp1 channel and normalizing the pixel intensity of all other samples to this constant. Additionally, several hundred individual Drp1 rings were measured using the Profile function of the ZEN 2012 image-processing platform and profile plot plugin (Plot Profile) from Fiji to determine the maximum and minimum ring diameters of constricted and dilated Drp1 rings. Based on this step, the threshold of object detection by the Object Profile algorithm was set to include Drp1 particles that exhibited a diameter between 100 (constricted) and 360 nm ([@bib32]; [@bib50]; [@bib66]; [@bib33]). Within this range, Drp1 aggregates with a ring size of \>180 nm were classified as dilated fission rings, and the aggregates with smaller diameter were considered to be of constricted form. Mitochondrial fission sites were defined by profiling regions of low mitochondrial intensity and high Drp1 signals along a linear path through mitochondrial fragments using the Plot Profile plugin from Fiji ([Fig. 4 A](#fig4){ref-type="fig"}).

The length of mitochondrial fragments was measured by a further modification of the Object Count plugin from Fiji. In brief, while keeping an equal threshold for all images, mitochondrial GFP fluorescence was converted to binary signals, and the algorithm was allowed to numerically categorize the mitochondria as a continuous network or individual fragment and finally determine the area covered by the mitochondrial fragments in micrometers squared. The area was divided by a factor of 0.39 nm, the mean width of HUVEC mitochondria determined by measuring ∼300 individual HUVEC mitochondrial fragments using the Profile function of ZEN 2012. Similarly, the length of H1299 p53^−/−^ mitochondrial fragments was determined by dividing the area by a factor of 0.46 nm. The mitochondrial fragments with no visible connections with neighboring networks were considered to be individual fragments. Cells with \>300 individual fragments were considered to be hyperfragmented, and ones with \<160 fragments were considered hyperfused.

Drp1 colocalization with the mitochondria was determined using the COLOC2 plugin from Fiji ([@bib70]; <http://imagej.net/Coloc_2>). The degree of colocalization was ascertained using Pearson's colocalization coefficient. Analysis of mitochondrial mobility was performed using MitoCRWLR (see Online supplemental material). In brief, the GFP channels of the movies were opened with Fiji. We measured differences for each of the pairs of two consecutive time frames and analyzed the area of each difference image by the Analyze Particles function of Fiji. At the same time, the total area of fluorescently labeled mitochondria was recorded and used to normalize the differences. Normalized mitochondrial differences of treated, infected, or control cells were thus determined in triplicate and plotted to visualize the impact of various treatments and *C. trachomatis* infection on mitochondrial mobility. Statistics of the measurements were analyzed using GraphPad Prism version 6.

Statistical analysis {#s30}
--------------------

All statistical calculations were performed using GraphPad Prism 6.0. Error bars displayed on graphs represent the means ± SD of three or more independent replicates of an experiment. D'Agostino--Pearson normality test was used to determine whether datasets were normally distributed ([Fig. 4 D](#fig4){ref-type="fig"}; [Fig. 5, B, C, G, and H](#fig5){ref-type="fig"}; and [Fig. 7, C and D](#fig7){ref-type="fig"}). Statistical significance was calculated using Student's *t* test or one-way analysis of variance followed by Tukey's multiple comparisons test. For image analysis, six or more biological replicates per sample-condition were used to generate the representative data. Western blot, qRT-PCR, Northern blot, cell viability, and ATP assay data presented are representative of at least three independent experiments.

Online supplemental material {#s31}
----------------------------

Fig. S1 shows validation and pathway analysis of the RNA sequencing data along with validation of miR-30c mimic, inhibitor, and sponges. We also demonstrate the effect of miRNA sponge on the infectivity of chlamydial progeny and mitochondrial integrity. Fig. S2 demonstrates the effect of Drp1 modulation on chlamydial inclusion sizes and the identification of Drp1 rings using SIM. Fig. S2 also illustrates the effect of peroxide exposure on miR-30c and p53 in infected and noninfected HUVECs. Fig. S3 details the effect of p53 overexpression on mitochondrial morphology, Drp1 expression, and chlamydial growth in H1299 p53^−/−^ cells. Fig. S4 shows matrix localization of the MitoTimer to the mitochondrial matrix. Fig. S4 also demonstrates the effect of DRP1 and p53 modulation on MitoTimer oxidation and ATP levels in different cell types. Videos 1 and 2 show live-cell imaging of mito-HUVECs with and without H~2~O~2~ treatment. Videos 3--6 show the effects of *C. trachomatis* infection and H~2~O~2~ on HUVECs expressing mitochondrially targeted GFP. Videos 7 and 8 are time-lapse confocal micrography of the effects of *C. trachomatis* infection in mito-HUVECs. The mitoCRWLR MACRO script was used to analyze the mitochondrial mobility of the GFP-tagged mitochondrial particles within live cells.
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